000 01402 a2200385 4500
005 20250516003513.0
264 0 _c20120924
008 201209s 0 0 eng d
022 _a1473-1150
024 7 _a10.1038/tpj.2010.69
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aJi, Y
245 0 0 _aCatechol O-methyltransferase pharmacogenomics and selective serotonin reuptake inhibitor response.
_h[electronic resource]
260 _bThe pharmacogenomics journal
_cFeb 2012
300 _a78-85 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _aCatechol O-Methyltransferase
_xgenetics
650 0 4 _aCell Line, Tumor
650 0 4 _aDepressive Disorder, Major
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aPharmacogenetics
_xmethods
650 0 4 _aPolymorphism, Single Nucleotide
650 0 4 _aSelective Serotonin Reuptake Inhibitors
_xtherapeutic use
650 0 4 _aTreatment Outcome
700 1 _aBiernacka, J
700 1 _aSnyder, K
700 1 _aDrews, M
700 1 _aPelleymounter, L L
700 1 _aColby, C
700 1 _aWang, L
700 1 _aMrazek, D A
700 1 _aWeinshilboum, R M
773 0 _tThe pharmacogenomics journal
_gvol. 12
_gno. 1
_gp. 78-85
856 4 0 _uhttps://doi.org/10.1038/tpj.2010.69
_zAvailable from publisher's website
999 _c20205859
_d20205859